Semmax Financial Advisors’s Gilead Sciences GILD Stock Holding History

Semmax Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$13.8K	Sell	116 -6	-5%	-$639	﹤0.01%	243
2025 Q1	$11.8K	Buy	122 +8	+7%	+$825	﹤0.01%	226
2024 Q4	$12.1K	Buy	114 +1	+0.9%	+$90	﹤0.01%	212
2024 Q3	$10.7K	Buy	113 +1	+0.9%	+$76	﹤0.01%	215
2024 Q2	$8.29K	Buy	112 +1	+0.9%	+$67	﹤0.01%	244
2024 Q1	$7.48K	Buy	111 +1	+0.9%	+$77	﹤0.01%	225
2023 Q4	$8.06K	Buy	110 +1	+0.9%	+$78	﹤0.01%	224
2023 Q3	$8.14K	Buy	+109	New	+$8.38K	﹤0.01%	201
2022 Q4	$9K	Buy	106 +1	+1%	+$79	﹤0.01%	176
2022 Q3	$9K	Buy	105 +2	+2%	+$126	﹤0.01%	164
2022 Q2	$7K	Buy	103 +1	+1%	+$62	﹤0.01%	174
2022 Q1	$6K	Buy	102 +1	+1%	+$64	﹤0.01%	209
2021 Q4	$7K	Buy	+101	New	+$6.96K	﹤0.01%	194

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Semmax Financial Advisors's GILD Position: Q2 2025 in Review

Semmax Financial Advisors reduced its Gilead Sciences (GILD) stake by 4.9% in Q2 2025, selling an estimated $639 and leaving 116 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

Semmax Financial Advisors first reported a position in GILD in Q4 2021 and has held it in 13 quarters since. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Semmax Financial Advisors held 116 shares of Gilead Sciences worth $13.8K as of Q2 2025.
Semmax Financial Advisors sold 6 Gilead Sciences shares in Q2 2025, an estimated $639.
Gilead Sciences made up ﹤0.01% of Semmax Financial Advisors's portfolio in Q2 2025, its #243 holding.
Semmax Financial Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 13 quarters since.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.